Venlafaxine ER
Venlafaxine ER is a pharmaceutical drug with 9 clinical trials. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
Clinical Trials (9)
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
Study Evaluating Venlafaxine ER in Adults With Panic Disorder
Study Evaluating Venlafaxine ER in Patients With Panic Disorder
Study Evaluating Venlafaxine ER in Recurrent Depression
Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9